Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription medications for people and animals with gastrointestinal distress, specifically debilitating chronic diarrhea. It operates through two reportable segments, Human Health and Animal Health. The company, through its subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants responsibly harvested from rainforest areas. It markets Mytesi, a crofelemer 125 mg delayed-release tablet for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral treatment. Develop Mytesi for multiple possible follow-up indications, including diarrhea related to targeted cancer therapy; orphan drug indications for infants and children with congenital diarrheal disorders and short bowel syndrome; supportive care for inflammatory bowel disease; irritable bowel syndrome; and for idiopathic/functional diarrhoea, as well as a second-generation proprietary antisecretory agent is under development for cholera. The company also develops Crofelemer, a drug candidate for chemotherapy-induced diarrhea in dogs. Jaguar Health, Inc. was incorporated in 2013 and is headquartered in San Francisco, California. a drug candidate for chemotherapy-induced diarrhea in dogs. Jaguar Health, Inc. was incorporated in 2013 and is headquartered in San Francisco, California. a drug candidate for chemotherapy-induced diarrhea in dogs. Jaguar Health, Inc. was incorporated in 2013 and is headquartered in San Francisco, California.
You are interested in buying shares of Jaguar Health (JAGX) – Tutorial
Do you want to buy Jaguar Health (JAGX) shares on Nasdaq with ease and through an officially regulated broker? Would you like to be able to monetize your bank earnings and have capital gains in the stock market? Here I am going to show you how easy it is to register a debit account , a reliable German investment broker and low commissions, and how you can get your first share in Jaguar Health, Inc. (JAGX) (JAGX) quickly and easily.
The method to follow is easy to follow :
- The first step is that we are going to register in degiro, a broker platform in which we will invest in the shares of the company Jaguar Health, Inc. (JAGX) – (JAGX).
- Then we will add €€€ and thus carry out our first investment.
- At the time we have the funds, we must locate the Jaguar Health company through its ticker, which is JAGX.
- To finish we will have to add the number of shares we want to buy, the price at which we will buy them and the type of order.
Perhaps the step by step has been a bit brief for you, so I am going to summarize the step by step with screenshots.
How to register an account in Degiro.
As a first step we will register in degiro with the following link :
It will ask us for an email, a username and a PIN code to access, and then we must continue using the link that they have sent us by e-mail.
Then degiro will ask us for essential information with which they will approve our identity . We need to have on hand the passport number, ID or driving license, your phone number and the bank account number that we are going to place to make our 1st deposit. If you do not understand what this format is, you can check this simple guide article that we have prepared at Educacep.es .
Once our account is accepted, we will be able to put money from the Enter/Withdraw section. We will be able to carry out a bank transaction that will take 1-2 days, or make the deposit instantly thanks to Sofort, a totally secure and very reliable payment gateway.
How to buy Jaguar Health (JAGX) shares via degiro
At the time that we have the capital we have the possibility of investing in our 1st action. You can select the “Place Order” button at the top right or use the DEGIRO search engine and type in the ticker. In the following image you will see that I have written the Amazon ticker but in your case you have to put (JAGX), the Jaguar Health ticker. Since we are talking about an action, we will detect that the related tickers are listed and there we will look to find Jaguar Health. The fundamental thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Jaguar Health, Inc. (JAGX) is listed on Nasdaq. This step is important so don’t get confused.
When making the order we have to pay special attention to what I am going to explain to you now . We will have the possibility of placing a limit or market order. Imagine that you want to get a share of Jaguar Health at 1.8000, but its price today is much higher. With a limit order we will place the value at which we calculate to carry out the operation and until there are no shares selling at a certain price, the acquisition of the share will not be executed. With a market order, Degiro will buy the number of shares that we have proposed at today’s selling price, which would be closely related to the current listing price.
In all cases it is essential that you look at the type of order: fixed or of the day . For example, in Spain, the stock market listing is in the morning and until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If the order is fixed, it will continue until the moment it is executed, but if you prefer the “of the day” option, at the moment the session ends, if it is not carried out, it will be deleted from your file from Activity – Pending Orders.
I would like this detailed tutorial to help you invest in Jaguar Health.
| Company information |
|
company executives
| Name | Title | Payment | exercised | Year of birth |
|---|---|---|---|---|
| Mrs. Lisa A. Conte | Founder, CEO, President and Director | 525.21k | N/A | 1959 |
| Mr. Jonathan S. Wolin CPA, JD, MBA | Chief of Staff, Chief Compliance Officer and General Counsel | 336.51k | N/A | 1962 |
| Dr Steven R King | Head of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Sec. | 332.23k | N/A | 1958 |
| Mrs. Carol R. Lizak | CFO | N/A | N/A | 1964 |
| Dr. Pravin R. Chaturvedi Ph.D. | Chairman of the Scientific Advisory Board and Interim Scientific Director | N/A | N/A | 1963 |
| Mr Peter Hodge | Senior Director of Investor Relations, Bus. Devel. & Special events | N/A | N/A | N/A |
| Mr. David Sesin | manufacturing manager | N/A | N/A | N/A |
| Mr. Ian H. Wendt MBA | Commercial Director | N/A | N/A | N/A |
| Mrs. Melissa A. Yeager J.D. | Senior Vice President of Regulatory Affairs and Quality Assurance | N/A | N/A | 1954 |
| Dr. Michael K. Guy DVM, MS, Ph.D. | Vice President of Preclinical and Nonclinical Studies | N/A | N/A | N/A |
Recent Jaguar Health Events:
Recent Events July 14, 2020 Filed Full 8-K: Entry into Definitive Material Agreement, Creation of Direct Financial Ob June 30, 2020 Filed Full 8-K: Disclosure, Financial Statements, and Schedules to Regulation FD June 26, 2020 Filed Complete 8-K: Change of Directors or Principal Officers June 19, 2020 Filed Complete 8-K: Change of Directors or Principal Officers, Financial Statements and Exhibits May 28, 2020 Filed Complete 8-K: Other Events